Identification of the Thioredoxin-Like 2 Autoantibody as a Specific Biomarker for Triple-Negative Breast Cancer-Reference-Cited by-同舟云学术

Identification of the Thioredoxin-Like 2 Autoantibody as a Specific Biomarker for Triple-Negative Breast Cancer

Published:2018 Issue:1 Volume:21 Page:87
ISSN:1738-6756
Container-title:Journal of Breast Cancer
language:en
Short-container-title:J Breast Cancer

Author:

Chung Jee Min¹²³,Jung Yongsik⁴,Kim Young Pil⁵,Song Jinsue⁵,Kim Soyeon¹²³,Kim Ji Young⁴,Kwon Mira¹²³,Yoon Jung Hyun¹²³,Kim Myo-Deok⁵,Lee Jun-kyoung¹,Chung Da-Yoon⁵,Lee Seo Yun¹²,Kang Jooseong⁵,Kang Ho Chul¹²³

Affiliation:

1. Genomic Instability Research Center, Ajou University School of Medicine, Suwon, Korea.

2. Department of Physiology, Ajou University School of Medicine, Suwon, Korea.

3. Department of Biomedical Sciences, Ajou University School of Medicine, Suwon, Korea.

4. Department of Surgery, Ajou University School of Medicine, Suwon, Korea.

5. Department of Bio-Engineering, Life Science RD Center, Sinil Pharmaceutical Co., Seongnam, Korea.

Funder

Ministry of Trade, Industry and Energy

Korea Health Industry Development Institute

National Research Foundation of Korea

Publisher

Korean Breast Cancer Society

Subject

Cancer Research,Oncology

Link

https://synapse.koreamed.org/pdf/10.4048/jbc.2018.21.1.87

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-TCP1 Antibody Is a Potential Biomarker for Diagnosing Systemic Lupus Erythematosus;International Journal of Molecular Sciences;2024-08-07

2. Autoantibodies as biomarkers for breast cancer diagnosis and prognosis;Frontiers in Immunology;2022-11-14

3. Evaluation of autoantibody signatures in pituitary adenoma patients using human proteome arrays;PROTEOMICS – Clinical Applications;2022-09-18

4. Autoantibodies as Clinical Biomarkers in Breast Cancer;Breast Cancer: Current Trends in Molecular Research;2022-07-14

5. An Autoantigen Atlas From Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19;Frontiers in Immunology;2022-03-24